🔗 Permalink

Inventor profile of:

James Wright

City:

Lexington, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-11-21

Top Assignees for applications by James Wright

The entities that hold a legal rights for patent applications filed by inventor Wright James:

Bind Therapeutics, Inc. 21 Cambridge, MA United States
PFIZER INC. 11 New York, NY United States
BIND BIOSCIENCES, INC 7 Cambridge, MA United States
Lyndra Therapeutics, Inc. 2 Watertown, MA United States
Alkermes Controlled Therapeutics II 1 Cambridge, MA United States

Recent patent applications by Wright James

James Wright from Lexington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-21

US20240382418A1

Human necessities

GASTRIC RESIDENCE SYSTEMS WITH RELEASE RATE-MODULATING FILMS

#2 | 2020-08-20

US20200261596A1

Human necessities

Therapeutic Particles with Peptide Boronic Acid or Boronate Ester Compounds and Methods of Making and Using Same

#3 | 2020-05-14

US20200146979A1

Human necessities

Gastric residence systems with release rate-modulating films

#4 | 2019-08-01

US20190231697A1

Human necessities

Gastric residence systems for sustained delivery of adamantane-class drugs

#5 | 2019-04-18

US20190111004A1

Human necessities

Therapeutic nanoparticles comprising a protonatable nitrogen therapeutic agent and methods of making and using same

#6 | 2017-09-21

US20170266293A1

Human necessities

METHODS OF TREATING CANCERS WITH THERAPEUTIC NANOPARTICLES

#7 | 2017-07-06

US20170189368A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#8 | 2017-05-04

US20170119672A1

Human necessities

Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods Of Making And Using Same

#9 | 2017-02-16

US20170042828A1

Human necessities

Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same

#10 | 2016-12-08

US20160356732A1

Physics

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#11 | 2016-11-24

US20160338963A1

Human necessities

Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same

#12 | 2016-06-02

US20160151298A1

Human necessities

DOCETAXEL POLYMERIC NANOPARTICLES AND METHODS OF TREATING CANCERS USING SAME

#13 | 2016-02-18

US20160045608A1

Human necessities

LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS

#14 | 2015-10-08

US20150283081A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#15 | 2015-01-15

US20150017245A1

Human necessities

METHODS OF TREATING CANCERS WITH THERAPEUTIC NANOPARTICLES

#16 | 2014-09-04

US20140249158A1

Human necessities

Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same

#17 | 2014-09-04

US20140248358A1

Human necessities

Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same

#18 | 2014-07-03

US20140186453A1

Human necessities

Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same

#19 | 2014-07-03

US20140186452A1

Human necessities

Process for preparing therapeutic nanoparticles

#20 | 2014-06-26

US20140178475A1

Human necessities

Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same

#21 | 2014-04-03

US20140093579A1

Human necessities

Long circulating nanoparticles for sustained release of therapeutic agents

#22 | 2014-01-30

US20140030351A1

Human necessities

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#23 | 2013-12-26

US20130344158A1

Human necessities

Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same

#24 | 2013-11-14

US20130302432A1

Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#25 | 2013-11-07

US20130295191A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#26 | 2013-11-07

US20130295183A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#27 | 2013-10-24

US20130280339A1

Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#28 | 2013-09-19

US20130243863A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#29 | 2013-09-12

US20130236500A1

Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#30 | 2013-09-05

US20130230568A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#31 | 2013-09-05

US20130230567A1

Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#32 | 2013-07-25

US20130189315A1

Human necessities

Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same

#33 | 2013-02-07

US20130034608A1

Human necessities

Long circulating nanoparticles for sustained release of therapeutic agents

#34 | 2012-11-15

US20120288541A1

Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#35 | 2012-11-01

US20120276162A1

Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#36 | 2012-06-07

US20120140790A1

Physics

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#37 | 2012-02-02

US20120027820A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#38 | 2011-12-01

US20110294717A1

Physics

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#39 | 2011-11-10

US20110275704A1

Human necessities

Stable formulations for lyophilizing therapeutic particles

#40 | 2011-09-08

US20110217377A1

Human necessities

Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents

#41 | 2010-08-26

US20100216804A1

Human necessities

Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents

#42 | 2010-04-29

US20100104655A1

Human necessities

Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same

#43 | 2010-03-18

US20100069426A1

Human necessities

Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same

#44 | 2010-03-18

US20100068285A1

Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#45 | 2006-02-23

US20060040922A1

Chemistry; metallurgy

Aripiprazole, olanzapine and haloperidol pamoate salts

#46 | 2005-02-10

US20050032836A1

Chemistry; metallurgy

Aripiprazole, olanzapine and haloperidol pamoate salts

InventorID:

78249 ⎘